RETRACTED: Severe Dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy") (Retracted Article)

被引:117
作者
Ricaurte, GA [1 ]
Yuan, J
Hatzidimitriou, G
Cord, BJ
McCann, UD
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurol, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurosci, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA
关键词
D O I
10.1126/science.1074501
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The prevailing view is that the popular recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, or "ecstasy") is a selective serotonin neurotoxin in animals and possibly in humans. Nonhuman primates exposed to several sequential doses of MDMA, a regimen modeled after one used by humans, developed severe brain dopaminergic neurotoxicity, in addition to less pronounced serotonergic neurotoxicity. MDMA neurotoxicity was associated with increased vulnerability to motor dysfunction secondary to dopamine depletion. These results have implications for mechanisms of MDMA neurotoxicity and suggest that recreational MDMA users may unwittingly be putting themselves at risk, either as young adults or later in life, for developing neuropsychiatric disorders related to brain dopamine and/or serotonin deficiency.
引用
收藏
页码:2260 / 2263
页数:5
相关论文
共 32 条
[21]   Memory deficits associated with recreational use of "ecstasy" (MDMA) [J].
Morgan, MJ .
PSYCHOPHARMACOLOGY, 1999, 141 (01) :30-36
[22]   Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain [J].
O'Shea, E ;
Esteban, B ;
Camarero, J ;
Green, AR ;
Colado, MI .
NEUROPHARMACOLOGY, 2001, 40 (01) :65-74
[23]   Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity [J].
Parrott, AC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (04) :837-844
[24]   Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research [J].
Parrott, AC .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (08) :557-577
[25]  
PEROUTKA SJ, 1987, NEW ENGL J MED, V317, P1542
[26]   (±)3,4-methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity:: Studies in animals [J].
Ricaurte, GA ;
Yuan, J ;
McCann, UD .
NEUROPSYCHOBIOLOGY, 2000, 42 (01) :5-10
[27]   (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE SELECTIVELY DAMAGES CENTRAL SEROTONERGIC NEURONS IN NONHUMAN-PRIMATES [J].
RICAURTE, GA ;
FORNO, LS ;
WILSON, MA ;
DELANNEY, LE ;
IRWIN, I ;
MOLLIVER, ME ;
LANGSTON, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (01) :51-55
[28]   TOXIC EFFECTS OF MDMA ON CENTRAL SEROTONERGIC NEURONS IN THE PRIMATE - IMPORTANCE OF ROUTE AND FREQUENCY OF DRUG ADMINISTRATION [J].
RICAURTE, GA ;
DELANNEY, LE ;
IRWIN, I ;
LANGSTON, JW .
BRAIN RESEARCH, 1988, 446 (01) :165-168
[29]   NEUROCHEMICAL AND NEUROHISTOLOGICAL ALTERATIONS IN THE RAT AND MONKEY PRODUCED BY ORALLY-ADMINISTERED METHYLENEDIOXYMETHAMPHETAMINE (MDMA) [J].
SLIKKER, W ;
ALI, SF ;
SCALLET, AC ;
FRITH, CH ;
NEWPORT, GD ;
BAILEY, JR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1988, 94 (03) :448-457
[30]   DIFFERENCES IN THE CENTRAL SEROTONERGIC EFFECTS OF METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN MICE AND RATS [J].
STONE, DM ;
HANSON, GR ;
GIBB, JW .
NEUROPHARMACOLOGY, 1987, 26 (11) :1657-1661